Publications by authors named "Sharon Yee"

Claim this Profile
C
Characterization of in vivo biotransformations for trastuzumab emtansine by high-resolution accurate-mass mass spectrometry.
Jintang He, Shang-Fan Yu, Sharon Yee, Surinder Kaur, Keyang Xu

MAbs· October 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Attachment Site Cysteine Thiol pK Is a Key Driver for Site-Dependent Stability of THIOMAB Antibody-Drug Conjugates.
Breanna S Vollmar, Binqing Wei, Rachana Ohri, Jianhui Zhou, Jintang He, Sharon Yee

Bioconjug Chem· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Modulating Therapeutic Activity and Toxicity of Pyrrolobenzodiazepine Antibody-Drug Conjugates with Self-Immolative Disulfide Linkers.
Thomas H Pillow, Melissa Schutten, Shang-Fan Yu, Rachana Ohri, Jack Sadowsky, Sharon Yee

Mol Cancer Ther· May 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Balancing Efficacy and Safety of an Anti-DLL4 Antibody through Pharmacokinetic Modulation.
Jessica A Couch, Gu Zhang, Joseph C Beyer, Christina L Zuch de Zafra, Priyanka Gupta, Sharon Yee

Clin Cancer Res· March 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting LGR5+ cells with an antibody-drug conjugate for the treatment of colon cancer.
Melissa R Junttila, Weiguang Mao, Xi Wang, Bu-Er Wang, Thinh Pham, Sharon Yee

Sci Transl Med· November 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mitigation of Acetylcholine Esterase Activity in the 1,7-Diazacarbazole Series of Inhibitors of Checkpoint Kinase 1.
Lewis Gazzard, Karen Williams, Huifen Chen, Lorraine Axford, Elizabeth Blackwood, Sharon Yee

J Med Chem· June 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An integrative analysis of colon cancer identifies an essential function for PRPF6 in tumor growth.
Adam S Adler, Mark L McCleland, Sharon Yee, Murat Yaylaoglu, Sofia Hussain

Genes Dev· May 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mapping in vivo tumor oxygenation within viable tumor by 19F-MRI and multispectral analysis.
Yunzhou Shi, Jason Oeh, Jeffrey Eastham-Anderson, Sharon Yee, David Finkle

Neoplasia· November 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combination drug scheduling defines a "window of opportunity" for chemopotentiation of gemcitabine by an orally bioavailable, selective ChK1 inhibitor, GNE-900.
Elizabeth Blackwood, Jennifer Epler, Ivana Yen, Michael Flagella, Tom O'Brien, Sharon Yee

Mol Cancer Ther· October 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
ImmunoPET imaging of phosphatidylserine in pro-apoptotic therapy treated tumor models.
Annie Ogasawara, Jeff N Tinianow, Alexander N Vanderbilt, Herman S Gill, Sharon Yee

Nucl Med Biol· January 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
TRAF2 Sets a threshold for extrinsic apoptosis by tagging caspase-8 with a ubiquitin shutoff timer.
Francois Gonzalvez, David Lawrence, Becky Yang, Sharon Yee, Robert Pitti

Mol Cell· December 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Erratum to: Ungersma SE, Pacheco G, Ho C, Yee SF, Ross J, van Bruggen N, Peale FV Jr, Ross S, Carano RA. Vessel imaging with viable tumor analysis for quantification of tumor angiogenesis. Magn Reson Med 2010;63:1637–1647.
Sharon E Ungersma, Glenn Pacheco, Calvin Ho, Sharon Fong Yee, Jed Ross

Magn Reson Med· March 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An Fcγ receptor-dependent mechanism drives antibody-mediated target-receptor signaling in cancer cells.
Nicholas S Wilson, Becky Yang, Annie Yang, Stefanie Loeser, Scot Marsters, Sharon Yee

Cancer Cell· January 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Vessel imaging with viable tumor analysis for quantification of tumor angiogenesis.
Sharon E Ungersma, Glenn Pacheco, Calvin Ho, Sharon Fong Yee, Jed Ross

Magn Reson Med· June 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cooperation of the proapoptotic receptor agonist rhApo2L/TRAIL with the CD20 antibody rituximab against non-Hodgkin lymphoma xenografts.
Dylan Daniel, Becky Yang, David A Lawrence, Klara Totpal, Inessa Balter, Sharon Fong Yee

Blood· December 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Death-receptor O-glycosylation controls tumor-cell sensitivity to the proapoptotic ligand Apo2L/TRAIL.
Klaus W Wagner, Elizabeth A Punnoose, Thomas Januario, David A Lawrence, Robert M Pitti, Sharon Fong Yee

Nat Med· September 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Blocking neuropilin-1 function has an additive effect with anti-VEGF to inhibit tumor growth.
Qi Pan, Yvan Chanthery, Wei-Ching Liang, Scott Stawicki, Judy Mak, Sharon Fong Yee

Cancer Cell· January 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis